Sign In
Buy CLVS
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Why Top Ships Shares Are Trading Lower By Over 60%; Here Are 24 Stocks Moving Premarket
01:16pm, Monday, 05'th Dec 2022 Benzinga
Gainers
Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 18.1% to $0.6316 in pre-market trading after jumping over 34% on Friday. Cosmos Holdings, last month, posted Q3 loss of $0.08 per share.
Zhihu
Dear CLVS Stock Fans, Get Ready for a Bankruptcy Filing
12:44pm, Monday, 05'th Dec 2022
Investors in Clovis Oncology (NASDAQ: CLVS ) stock will want to prepare for a bankruptcy filing following a warning from the pharmaceutical company. According to a filing with the U.S. Securities and
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
05:34pm, Friday, 25'th Nov 2022 Zacks Investment Research
Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term.
Clovis (CLVS) Stock Down 50% in the Past 6 Months: Here's Why
02:18pm, Friday, 25'th Nov 2022
Clovis Oncology (CLVS) tanks in the past six months following the possibility of a bankruptcy filing in the near term.
Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)
02:35pm, Monday, 21'st Nov 2022 Zacks Investment Research
Clovis (CLVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea
Down 67.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Clovis (CLVS)
11:17am, Monday, 21'st Nov 2022
Clovis (CLVS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ea
7 Stocks to Sell Right Now
01:11pm, Friday, 18'th Nov 2022
Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I'm just going to stic
Best Penny Stocks To Buy? 7 To Watch Under $1 Right Now
05:22pm, Tuesday, 15'th Nov 2022 PennyStocks
Penny stocks to buy for under $1 but are they worth the risk?
The post Best Penny Stocks To Buy? 7 To Watch Under $1 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
Best Penny Stocks To Buy? 7 To Watch Under $1 Right Now
12:22pm, Tuesday, 15'th Nov 2022
Penny stocks to buy for under $1 but are they worth the risk? The post Best Penny Stocks To Buy?
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
10:19am, Tuesday, 15'th Nov 2022 Benzinga
Gainers
Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus contin
Clovis Oncology (CLVS) Stock Pops After Bankruptcy Warning
03:28pm, Monday, 14'th Nov 2022
There's nothing like a good old-fashioned bankruptcy warning to make a stock pop on a given day. Today, the latest speculative frenzy appears to be underway with Clovis Oncology (NASDAQ: CLVS ).
What You Might Have Missed: Eggs, Chicken and Apple
01:24pm, Saturday, 12'th Nov 2022 Investing.com
Clovis (CLVS) Plummets on News of Possible Bankruptcy Filing
03:46pm, Thursday, 10'th Nov 2022 Zacks Investment Research
Clovis (CLVS) tanks following the possibility of a bankruptcy filing in the near term after recent regulatory developments impacted current revenues and the commercial potential of Rubraca.
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
02:11pm, Thursday, 10'th Nov 2022 Benzinga
Upgrades
According to Stifel, the prior rating for Clearside Biomedical Inc (NASDAQ:CLSD) was changed from Hold to Buy. In the third quarter, Clearside Biomedical showed an EPS of $0.13, compared to $
Clovis (CLVS) Plummets on News of Possible Bankruptcy Filing
12:02pm, Thursday, 10'th Nov 2022
Clovis (CLVS) tanks following the possibility of a bankruptcy filing in the near term after recent regulatory developments impacted current revenues and the commercial potential of Rubraca.
